| Dr Luis J Rivera-ramos, MD | |
|
100 Paseo San Pablo, Edif. Arturo Cadilla Suite 406, Bayamon, PR 00961 | |
| (787) 395-7072 | |
| (787) 395-7074 |
| Full Name | Dr Luis J Rivera-ramos |
|---|---|
| Gender | Male |
| Speciality | Neurology |
| Experience | 21 Years |
| Location | 100 Paseo San Pablo, Bayamon, Puerto Rico |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265630172 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084N0400X | Psychiatry & Neurology - Neurology | 16830 (Puerto Rico) | Primary |
| Entity Name | Cdt Gmsp Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417922972 PECOS PAC ID: 1355317751 Enrollment ID: O20040908000092 |
News Archive
Fibroid uterine tumors affect an estimated 15 million women in the United States, causing irregular bleeding, anemia, pain and infertility. Despite the high prevalence of the tumors, which occur in 60 percent of women by age 45, the molecular cause has been unknown.
BioCryst Pharmaceuticals, Inc. announced that its partner, Green Cross Corporation has received marketing and manufacturing approval from KFDA for intravenous peramivir to treat patients with influenza A & B viruses, including pandemic H1N1 and avian influenza. Green Cross Corp. intends to launch peramivir under the commercial name PeramiFlu in South Korea.
Watson Pharmaceuticals, Inc., today announced the U.S. commercial launch of Generess Fe 0.8 mg/25 mcg, a new low-dose oral contraceptive option that's highly effective at preventing pregnancy and proven to provide users with short, lighter, predictable periods.
Scientists who search for new pesticides for use in humanity's battle of the bugs and other threats to the food supply have been learning lessons from Mother Nature, according to a new analysis. It concludes that more than two out of every three new pesticide active ingredients approved in recent years had roots in natural substances produced in plants or animals. The article appears in ACS' Journal of Natural Products.
The idea is to teach the immune system of children at high risk for type 1 diabetes not to attack the insulin-producing cells of the pancreas.
› Verified 7 days ago
| Entity Name | Centro Medico Del Turabo Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710107883 PECOS PAC ID: 9335051952 Enrollment ID: O20080212000105 |
News Archive
Fibroid uterine tumors affect an estimated 15 million women in the United States, causing irregular bleeding, anemia, pain and infertility. Despite the high prevalence of the tumors, which occur in 60 percent of women by age 45, the molecular cause has been unknown.
BioCryst Pharmaceuticals, Inc. announced that its partner, Green Cross Corporation has received marketing and manufacturing approval from KFDA for intravenous peramivir to treat patients with influenza A & B viruses, including pandemic H1N1 and avian influenza. Green Cross Corp. intends to launch peramivir under the commercial name PeramiFlu in South Korea.
Watson Pharmaceuticals, Inc., today announced the U.S. commercial launch of Generess Fe 0.8 mg/25 mcg, a new low-dose oral contraceptive option that's highly effective at preventing pregnancy and proven to provide users with short, lighter, predictable periods.
Scientists who search for new pesticides for use in humanity's battle of the bugs and other threats to the food supply have been learning lessons from Mother Nature, according to a new analysis. It concludes that more than two out of every three new pesticide active ingredients approved in recent years had roots in natural substances produced in plants or animals. The article appears in ACS' Journal of Natural Products.
The idea is to teach the immune system of children at high risk for type 1 diabetes not to attack the insulin-producing cells of the pancreas.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Luis J Rivera-ramos, MD 35 Calle Juan C. Borbon, Suite 67 Pmb 314, Guaynabo, PR 00969-5375 Ph: (787) 395-7072 | Dr Luis J Rivera-ramos, MD 100 Paseo San Pablo, Edif. Arturo Cadilla Suite 406, Bayamon, PR 00961 Ph: (787) 395-7072 |
News Archive
Fibroid uterine tumors affect an estimated 15 million women in the United States, causing irregular bleeding, anemia, pain and infertility. Despite the high prevalence of the tumors, which occur in 60 percent of women by age 45, the molecular cause has been unknown.
BioCryst Pharmaceuticals, Inc. announced that its partner, Green Cross Corporation has received marketing and manufacturing approval from KFDA for intravenous peramivir to treat patients with influenza A & B viruses, including pandemic H1N1 and avian influenza. Green Cross Corp. intends to launch peramivir under the commercial name PeramiFlu in South Korea.
Watson Pharmaceuticals, Inc., today announced the U.S. commercial launch of Generess Fe 0.8 mg/25 mcg, a new low-dose oral contraceptive option that's highly effective at preventing pregnancy and proven to provide users with short, lighter, predictable periods.
Scientists who search for new pesticides for use in humanity's battle of the bugs and other threats to the food supply have been learning lessons from Mother Nature, according to a new analysis. It concludes that more than two out of every three new pesticide active ingredients approved in recent years had roots in natural substances produced in plants or animals. The article appears in ACS' Journal of Natural Products.
The idea is to teach the immune system of children at high risk for type 1 diabetes not to attack the insulin-producing cells of the pancreas.
› Verified 7 days ago
Dr. Lesbia Aponte, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 100 Paseo San Pablo, Cadilla Bldg.,suite 203, Bayamon, PR 00961 Phone: 787-798-2975 Fax: 787-787-9619 | |
Dr. Fernando Entenza, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: Plaza Laurel 300, Laurel Avenue, Santa Juanita, Bayamon, PR 00959 Phone: 782-288-0277 Fax: 787-966-7923 | |
Ruben L Bravo Valverde Sr., MD Psychiatry & Neurology Medicare: May Accept Medicare Assignments Practice Location: Comdominio Las Torres, Sur 1-b, Bayamon, PR 00959 Phone: 787-780-3752 Fax: 787-787-0412 | |
Madeline Santos-carlo, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: Carr #2 Km 119, Suite 102 Medical Ophthalmic Plaza, Bayamon, PR 00959 Phone: 787-786-3340 Fax: 787-786-3331 | |
Dr. Carlos R. Lao Velez, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: Condominio Las Torres Norte, Oficina 1b, Bayamon, PR 00959 Phone: 787-780-1280 Fax: 787-780-1280 | |
Dr. Miguel Angel Rivera, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 41 Calle Santa Cruz, Bayamon, PR 00961 Phone: 787-778-2800 Fax: 787-273-7509 | |
Dr. Lizbeth Robles Irizarry, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 2 Calle 1 Esquina 3b Marginal, Suite G1, Urb. Hermanas Davila, Bayamon, PR 00960 Phone: 787-966-7500 Fax: 787-966-7505 |